MEOX2 and lung carcinoma: The primary goal of this study was to identify gene promoter targets of the HOX-related gene transcription factor MEOX2 in human solid lung carcinomas, to identify and propose new mechanisms, e.g., transcriptional axes, involved in lung oncological treatment resistance, and to characterize the association between clinical progression and overall survival in lung cancer patients.